A Phase II Clinical Trial Evaluating the Efficacy and Safety of SYS6026 Injection in Participants With HPV16 or 18-related High-grade Cervical Squamous Intraepithelial Lesions
Conditions : High-grade Cervical Intraepithelial Lesions Interventions : Biological: SYS6026; Biological: Placebo Sponsors : CSPC Megalith Biopharmaceutical Co.,Ltd. Not yet recruiting
Read the full article3d agoen
You might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Pooled analysis of over 120 clinical trials finds no increased cardiovascular risk with sildenafil (Viagra)
pubmed.ncbi.nlm.nih.gov·24m agoThe future of US psychedelic medicine is carved out by the FDA
refractor.io·31m ago
Umoja Receives FDA IND Clearance for CD22-Directed In Vivo CAR-T Therapy
PackGene Biotech·1h ago
Johnson & Johnson Discontinues JNJ-1887 Gene Therapy Program for Geographic Atrophy
PackGene Biotech·1h ago
Cancro al pancreas, la speranza di un vaccino per prevenirlo: lo studio e i primi test
Adnkronos·3h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.